Committed to Providing Advanced Cancer Detection and Treatment Options For Unparalleled Care
3 Million+ U.S. Non-Melanoma Skin Cancer Cases Diagnosed Annually
Revolutionizing Skin Cancer Treatment With a
Painless, Isotope-free Approach
Learn more about Skin eBx®
Breast Cancer Treatment in as Little as 1 Day
More than 1,000 Early Stage Breast Cancer Patients Treated With Intraoperative
Radiation Therapy (IORT)
Learn more about IORT
In The News
Xoft® is the only FDA cleared electronic brachytherapy (eBx®) system that has been used to treat 3,000 non-melanoma skin
cancer patients & is supported by positive
3-year clinical data.
iCAD is committed to providing advanced cancer detection and treatment options for unparalleled care.
Learn more about CAD technology and Xoft® eBx® for your cancer treatment.
Surgery is not the only option.
Learn more about eBx® for non-melanoma skin cancer treatment.
IORT & APBI
“I came in with cancer, went to sleep, and when I woke up, I was completely done with my breast cancer treatment.”
–Marianne, IORT Patient Learn more.
Learn more about GYN eBx® for your gynecological cancer treatment.
Computer-Aided Detection (CAD)
iCAD technology helps physicians and patients in the fight against the most prevalent cancers: breast, colorectal, and prostate. Learn more about CAD.
iCAD Inc., Announces Closing of Underwritten Public Offering of Common Stock
iCAD Announces More Than 1,000 Early Stage Breast Cancer Patients Treated With Intraoperative Radiation Therapy (IORT) Using the Xoft® System
iCAD, Inc. Announces Proposed Public Offering of Common Stock
Copyright © 2014, iCAD Inc. All rights reserved. Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are registered trademarks of iCAD, Inc.